Actual Medicinal Product (AMP) Isentress 400mg tablets (Merck Sharp & Dohme (UK) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: Store in airtight containers. Soluble in water.
Provenance: This compatibility recommendation is derived from Isentress 400mg tablets (Merck Sharp & Dohme (UK) Ltd).
Generic: Raltegravir
Formulation: Raltegravir 400mg tablets

Raltegravir
- Raltegravir 400mg tablets
  - Isentress 400mg tablets (Merck Sharp & Dohme (UK) Ltd)